PPT-Update from CROI 2023: Snippets from Seattle

Judith S Currier MD MSc Professor of Medicine University of California Los Angeles Financial Relationships With Ineligible Companies Formerly Described as Commercial Interests by the ACCME Within the Last 2 Years. Summarizing Web Pages for Search and Revisitation. Jaime Teevan, Ed Cutrell, Danyel Fisher, Steven Drucker, . G. onzalo Ramos, Paul André. 1. , Chang Hu. 2. Microsoft Corporation. 1. University of Southampton . Nina Kim, MD . Associate Professor of Medicine. Division of Allergy & Infectious Diseases. University of Washington. No financial conflicts of interest. ION-4. Ledipasvir-Sofosbuvir. for 12 weeks. Summarizing Web Pages for Search and Revisitation. Jaime Teevan, Ed Cutrell, Danyel Fisher, Steven Drucker, . G. onzalo Ramos, Paul André. 1. , Chang Hu. 2. Microsoft Corporation. 1. University of Southampton . Jared Kadry – Market Analyst. Fundamentals. Fundamentals. Seattle Historical Employment Growth. Apartment Fundamentals. Apartment Fundamentals- Near Term Forecast. Fundamentals. Supply. Supply. Seattle Metro Apartment Inventory. 1 Queen Mary University, London, United Kingdom; 2 EPIMED GmbH, Berlin, Germany; 3 Hospital Universitario Fundación Jiménez Díaz , Madrid, Spain; 4 Central Institute of Epidemiology, Moscow, Russian Federation; 1 University of Nebraska Medical Center, Omaha, NE, United States; 2 University of Guadalajara, Guadalajara, Mexico; 3 Broward Health Medical Center, Fort Lauderdale, FL, United States; 4 Fatebenefratelli Sacco Hospital, Milan, Italy; p. resented by. NCATEC. March . 18, . 2014. David . Wohl. , MD. Joe . Eron. , MD. Conference Call Line: (. 919) 962-. 2731 - Please mute your phones.. CROI 2014 Update: Implications for the Future of HIV Management. Résumé scientifique des principales études cliniques présentées à la CROI 2019. CAHR is pleased to provide this scientific summary of the major clinical studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2019). The synthesis aims to improve the cascade of care by increasing the skills and knowledge of Canadian health care professionals working in the realm of HIV. This presentation was made possible with the support of an educational grant from ViiV Healthcare.. AND OPPORTUNISTIC INFECTIONS. CROI 2023. 19-23 FEBRUARY 2023. Faculty. Pedro . Cahn. , Buenos-Aires, Argentina. Anton . Pozniak. , London, UK. François . Raffi. , Nantes, France. Long Acting Therapies. Prediction. . of . events. . after. ART. initiation. INSTI . and IRIS ?. Test and . Treat. Same. Day. Switch DTG/ABC/3TC. to BIC/F/TAF. Miscellaneous. ART. Test and Treat the Same Day - Is this feasible ?. Shireesha Dhanireddy. Robert Harrington. March 17, 2014. No financial conflicts of interest. Outline. Treatment Studies. Tenofovir. . alafenamide. (TAF) in a single-tablet regimen in initial HIV-1 infection . Jeffrey Lennox, MD. Professor of Medicine. Emory University. Atlanta. , Georgia. Financial Relationships With Ineligible Companies (Formerly Described as Commercial Interests by the ACCME) Within the Last 2 Years:. 2. C Brinson,. 3. F Castelli,. 4. P-M Girard,. 5. LP Kahl,. 6. . E Blair,. 7. B Wynne,. 8. K Vandermeulen,. 9. M Aboud. 10. . SWORD 1 & 2: Switch to . DTG + RPV Maintains Virologic . Suppression Through 48 Weeks, a Phase III Study. AND OPPORTUNISTIC INFECTIONS. (CROI 2020). BOSTON| 8-11 MARCH 2020. Faculty. Pedro . Cahn. , Buenos-Aires, Argentina. Anton . Pozniak. , London, UK. François . Raffi. , Nantes, France. This presentation is made in complete editorial freedom .